These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29562182)

  • 1. Ligand Binding Site Structure Influences the Evolution of Protein Complex Function and Topology.
    Abrusán G; Marsh JA
    Cell Rep; 2018 Mar; 22(12):3265-3276. PubMed ID: 29562182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-Binding-Site Structure Shapes Allosteric Signal Transduction and the Evolution of Allostery in Protein Complexes.
    Abrusán G; Marsh JA
    Mol Biol Evol; 2019 Aug; 36(8):1711-1727. PubMed ID: 31004156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand Binding Site Structure Shapes Folding, Assembly and Degradation of Homomeric Protein Complexes.
    Abrusán G; Marsh JA
    J Mol Biol; 2019 Sep; 431(19):3871-3888. PubMed ID: 31306664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Assessment of Quaternary Structure Functionality in Homomer Protein Complexes.
    Abrusán G; Foguet C
    Mol Biol Evol; 2023 Apr; 40(4):. PubMed ID: 36947103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands and Receptors with Broad Binding Capabilities Have Common Structural Characteristics: An Antibiotic Design Perspective.
    Abrusán G; Marsh JA
    J Med Chem; 2019 Nov; 62(21):9357-9374. PubMed ID: 31188598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of structural pleiotropy and regulatory evolution in the retention of heteromers of paralogs.
    Marchant A; Cisneros AF; Dubé AK; Gagnon-Arsenault I; Ascencio D; Jain H; Aubé S; Eberlein C; Evans-Yamamoto D; Yachie N; Landry CR
    Elife; 2019 Aug; 8():. PubMed ID: 31454312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of Rossmann-like domains reveals convergent evolution of topology and reaction pathways.
    Medvedev KE; Kinch LN; Schaeffer RD; Grishin NV
    PLoS Comput Biol; 2019 Dec; 15(12):e1007569. PubMed ID: 31869345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly reflects evolution of protein complexes.
    Levy ED; Boeri Erba E; Robinson CV; Teichmann SA
    Nature; 2008 Jun; 453(7199):1262-5. PubMed ID: 18563089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties.
    Almabouada F; Diaz-Ruiz A; Rabanal-Ruiz Y; Peinado JR; Vazquez-Martinez R; Malagon MM
    J Biol Chem; 2013 Feb; 288(5):3112-25. PubMed ID: 23255609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.
    Pou C; Mannoury la Cour C; Stoddart LA; Millan MJ; Milligan G
    J Biol Chem; 2012 Mar; 287(12):8864-78. PubMed ID: 22291025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
    Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
    Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacology: in silico methods of ligand design and development.
    McKie SA
    Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical function.
    Skolnick J; Gao M; Roy A; Srinivasan B; Zhou H
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1163-70. PubMed ID: 25690787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Perspectives on the Evolutionary Expansion of Unique Protein-Protein Binding Sites.
    Goncearenco A; Shaytan AK; Shoemaker BA; Panchenko AR
    Biophys J; 2015 Sep; 109(6):1295-306. PubMed ID: 26213149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design.
    Liang J; Edelsbrunner H; Woodward C
    Protein Sci; 1998 Sep; 7(9):1884-97. PubMed ID: 9761470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the Existence of a Metastable Binding Site at the β
    Gaiser BI; Danielsen M; Marcher-Rørsted E; Røpke Jørgensen K; Wróbel TM; Frykman M; Johansson H; Bräuner-Osborne H; Gloriam DE; Mathiesen JM; Sejer Pedersen D
    J Med Chem; 2019 Sep; 62(17):7806-7839. PubMed ID: 31298548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cofactor-binding sites in proteins of deviating sequence: comparative analysis and clustering in torsion angle, cavity, and fold space.
    Stegemann B; Klebe G
    Proteins; 2012 Feb; 80(2):626-48. PubMed ID: 22095739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of protein conformations for structure-based polypharmacology studies.
    Pinzi L; Caporuscio F; Rastelli G
    Drug Discov Today; 2018 Nov; 23(11):1889-1896. PubMed ID: 30099123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.